Molecule Holdings Inc.
EVRRFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$626130
P/E Ratio—
52W High$0.0025
52W Low$0.0025
Molecule Holdings Inc. (EVRRF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EVRRF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-10 | 2021-10 | 2020-10 | 2019-10 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $1.97M | $0.46M | $0.00M | $0.00M |
| Cost of Revenue | $3.04M | $0.95M | $0.05M | $0.03M |
| Gross Profit | ($1.07M) | ($0.50M) | ($0.05M) | ($0.03M) |
| Gross Margin %(computed) | -54.56% | -109.77% | — | — |
| Operating Expenses | ||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $2.59M | $2.43M | $1.88M | $1.07M |
| Total Operating Expenses | $2.84M | $2.89M | $1.83M | $1.10M |
| Operating Income | ($3.91M) | ($3.19M) | ($1.88M) | ($1.08M) |
| Operating Margin %(computed) | -198.86% | -701.11% | — | — |
| Interest Income | $0.00M | $0.00M | $0.01M | $0.02M |
| Interest Expense | $0.63M | $0.66M | $0.04M | $0.02M |
| Income Before Tax | ($4.54M) | ($4.23M) | ($3.33M) | ($1.09M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.02M |
| Net Income | ($4.54M) | ($4.23M) | ($3.33M) | ($1.09M) |
| Net Margin %(computed) | -230.84% | -928.56% | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-0.05 | $-0.05 | $-0.03 | $-0.24 |
| Wtd Avg Shares | 97.11M | 91.86M | 75.71M | 4.66M |
| EBITDA | ($3.26M) | ($2.87M) | ($3.23M) | ($1.05M) |
| EBITDA Margin %(computed) | -165.47% | -631.46% | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · M
Explore more Molecule Holdings Inc. data
About Molecule Holdings Inc. (EVRRF) Income Statement
Molecule Holdings Inc. (EVRRF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, EVRRF reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -54.56%), and net income of ($0.00B) — a net profit margin of -230.84%.
Frequently asked questions
EVRRF · 4 questionsMolecule Holdings Inc. (EVRRF) reported revenue of $0.00B for 2022, up 332.4% year-over-year.
EVRRF revenueEVRRF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09